Trial Profile
The Effect of Dexmedetomidine on Decreasing Emergence Agitation and Delirium in Pediatric Patients Undergoing Strabismus Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Agitation; Delirium
- Focus Therapeutic Use
- 15 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 26 Jan 2012 New trial record